Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Biophytis Biopharmaceutical
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Pre-financed vouchers (PFW)
    • Obligations Hexagon
    • Obligations Hexagon
    • Contact for Investors
  • Contact

    TNC FlipBook Classic items

    2023-02-23_PR-AGM_30_March_EN

    By adminNovember 1, 2025

    2023-02-23_CP-AGM_30_mars_FR

    By adminNovember 1, 2025

    2023-03-09_CP_LungScienceConf_FR

    By adminNovember 1, 2025

    2023-03-01_PR_Exploit_Pharm

    By adminNovember 1, 2025

    2024_03_27_CP_Acces_Precoce_France_EN

    By adminNovember 1, 2025

    2023-03-20_CP_MDA

    By adminNovember 1, 2025

    2023-03-17_PR_ADR_ratio_change

    By adminNovember 1, 2025

    2023-03-17_CP_Changement_de_ration_ADR

    By adminNovember 1, 2025

    2023-03-09_PR_LungScienceConf_EN

    By adminNovember 1, 2025

    2023_03_31_CP_Convocation_2eAG

    By adminNovember 1, 2025
    โ†1
    2345678910
    …1112131415…
    161718192021222324252627282930313233
    34โ†’
    X
    Addresses
    Addresses

    BIOPHYTIS France
    Silver Innov’
    54 rue Moliรจre
    94200 Ivry-Sur-Seine
    FRANCE

    Addresses

    BIOPHYTIS USA
    c/o NGIN
    210 Broadway, Suite #201
    Cambridge, MA 02139
    USA

    Addresses

    BIOPHYTIS Brazil
    CIETEC
    Av. Prof. Lineu Prestes
    2242 Cidade Universitรกria USP
    05508-000 Sรฃo Paulo
    BRASIL

    Contact
    contact@biophytis.com +33 1 76 28 40 83
    Investors

    investors@biophytis.com

    ยฉ Biophytis 2025.

    All Rights Reserved.

    Legal information
    Webdesign by Ex Calibra
    Go to Top
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact